NCT05705921View on ClinicalTrials.gov

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

January 1, 2032

Study Completion Date

January 1, 2032

Conditions
Prostate Cancer
Interventions
RADIATION

Radiotherapy standard

Standard moderately hypofractionated radiotherapy in prostate cancer

RADIATION

Radiotherapy Hypo-FLAME

Ultra-hypofractionated focal lesion ablative microboost in prostate cancer

Trial Locations (1)

1066 CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

The Netherlands Cancer Institute

OTHER